NDC 63629-1069-01 - Spironolactone and Hydrochlorothiazide
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 63629-1069
- Requested NDC
- 63629-1069-01
- Package NDCs from labels
- 63629-1069-1, 63629-1069-01
- Manufacturer
- Bryant Ranch Prepack
- Effective date
- 2026-03-12
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Spironolactone and Hydrochlorothiazide - Bryant Ranch Prepack | Bryant Ranch Prepack | 2026-03-12 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 63629-1069-1 | Spironolactone and Hydrochlorothiazide | 500 in 1 BOTTLE, PLASTIC | TABLET | 500 | 9 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 63629-1069 | SPIRONOLACTONE AND HYDROCHLOROTHIAZIDE TABLET [BRYANT RANCH PREPACK] | 7 | Current NDC, Legacy NDC, 1 package rows | 20240602_905568ae-ce27-4978-90c7-b5c93279ecd1.zip |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 63629-1069-1 | EA - Each | 63629-1069 | 6255dfc0-9893-430f-836d-b3fb04dc2dab | 1 | 2020-07-13 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| SPIRONOLACTONE | SPIRONOLACTONE | NCS HealthCare of KY, LLC dba Vangard Labs | e34fc3ca-1272-446b-8dc2-25b62add01c3 | 2024-08-05 | Warnings, Adverse reactions | 27O7W4T232 |
| Spironolactone and Hydrochlorothiazide | SPIRONOLACTONE AND HYDROCHLOROTHIAZIDE | Bryant Ranch Prepack | cc58a6a5-5ccd-451c-837c-781d0a8da5cf | 2024-08-05 | Warnings, Adverse reactions | ANDA089534 198224 0J48LPH2TH 27O7W4T232 |
| Stool Softener Laxative | DOCUSATE SODIUM | Proficient Rx LP | ccfa095c-77f0-41ff-84f8-e02d983c7c74 | 2024-08-01 | Warnings | F05Q2T2JA0 |
| Mind Detox and Drainage | ALUMINA, BARYTA CARBONICA, CARBONEUM SULPHURATUM, CEREBRUM SUIS, CONIUM MACULATUM, HELLEBORUS NIGER, LECITHIN, LYCOPODIUM CLAVATUM, MANDRAGORA OFFICINARUM, MERCURIUS SOLUBILIS, NAJA TRIPUDIANS, PICRICUM ACIDUM, PLATINUM METALLICUM, SILICEA, STRAMONIUM, SULPHURICUM ACIDUM, ZINCUM PHOSPHORATUM | Deseret Biologicals, Inc. | 1ac1e955-a374-4cac-b997-51c6aef8d35d | 2024-08-01 | Warnings | LMI26O6933 ETJ7Z6XBU4 |
| Spironolactone | SPIRONOLACTONE | Jubilant Cadista Pharmacuticals Inc. | c1c5fdab-3ff7-414b-8e25-beed8311b8ad | 2024-08-01 | Warnings, Adverse reactions | 27O7W4T232 |
| Stool Softener | DOCUSATE SODIUM SENNOSIDES | QUALITY CHOICE (Chain Drug Marketing Association) | d4128fbd-32ba-4d2e-ae1a-cbe438f5b39b | 2024-07-31 | Warnings | F05Q2T2JA0 |
| Olmesartan Medoxomil and Hydrochlorothiazide | OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE | A-S Medication Solutions | b78ad43f-f132-4f03-8c85-2cf9b3ab555b | 2024-07-30 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| Stool Softener Laxative Plus Stimulant | DOCUSATE SODIUM AND SENNOSIDES | Walgreens | db528659-768a-46e0-a340-9fbcdb25ea5e | 2024-07-25 | Warnings | F05Q2T2JA0 |
| HYDROCHLOROTHIAZIDE | HYDROCHLOROTHIAZIDE | NuCare Pharmaceuticals,Inc. | 1e02787f-ccb5-abc2-e063-6294a90af7c3 | 2024-07-24 | Warnings, Adverse reactions | 0J48LPH2TH |
| Stimulant Laxative Plus Stool Softener | DOCUSATE SODIUM AND SENNOSIDES | GOOD SENSE | 17cdef7b-71bf-b4a6-e063-6294a90a5b74 | 2024-07-22 | Warnings | F05Q2T2JA0 |
| Lisinopril and Hydrochlorothiazide | LISINOPRIL AND HYDROCHLOROTHIAZIDE | NuCare Pharmaceuticals, Inc. | 4af326db-bf2d-5310-e054-00144ff88e88 | 2024-07-19 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| Lisinopril and Hydrochlorothiazide | LISINOPRIL AND HYDROCHLOROTHIAZIDE | NuCare Pharmaceuticals,Inc. | 7cc69c16-0dcc-874d-e053-2991aa0a9919 | 2024-07-17 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| Lisinopril and Hydrochlorothiazide | LISINOPRIL AND HYDROCHLOROTHIAZIDE TABLETS | NuCare Pharmaceuticals,Inc. | af74c331-7402-408c-e053-2a95a90a1043 | 2024-07-17 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| Lisinopril and Hydrochlorothiazide | LISINOPRIL AND HYDROCHLOROTHIAZIDE TABLETS | NuCare Pharmaceuticals,Inc. | b2e8b3bb-0ab5-ffd7-e053-2995a90aa2b6 | 2024-07-17 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| Lisinopril and Hydrochlorothiazide | LISINOPRIL AND HYDROCHLOROTHIAZIDE TABLETS | NuCare Pharmaceuticals,Inc. | b4c9abf7-a2c6-7042-e053-2a95a90a7653 | 2024-07-17 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| Lisinopril and hydrochlorothiazide | LISINOPRIL AND HYDROCHLOROTHIAZIDE | NuCarePharmaceuticals, Inc. | 4fbf31a1-037b-31a2-e054-00144ff88e88 | 2024-07-17 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| Spironolactone | SPIRONOLACTONE | Jubilant Cadista Pharmacuticals Inc. | a7510768-8a52-4230-6aa0-b0d92d82588f | 2024-07-17 | Warnings, Adverse reactions | 27O7W4T232 |
| Triamterene and Hydrochlorothiazide | TRIAMTERENE AND HYDROCHLOROTHIAZIDE | NuCare Pharmaceuticals,Inc. | 7c214ebf-e0ed-6538-e053-2991aa0a8079 | 2024-07-16 | Warnings, Adverse reactions | 0J48LPH2TH |
| Lisinopril and Hydrochlorothiazide | LISINOPRIL AND HYDROCHLOROTHIAZIDE | NuCare Pharmaceuticals, Inc. | 4925a3ad-63bd-108a-e054-00144ff8d46c | 2024-07-15 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| Spironolactone | SPIRONOLACTONE | NuCare Pharmaceuticals, Inc. | 540ee876-78fb-1792-e054-00144ff88e88 | 2024-07-10 | Boxed warning, Warnings, Adverse reactions | 27O7W4T232 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.